Human Cells, Tissues, and Cellular and Tissue-Based Products, 3387 [08-55500]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 13 / Friday, January 18, 2008 / Rules and Regulations
3. SC 23.1199—Add the requirements
of § 23.1199 while deleting the phrase,
‘‘For commuter category airplanes.’’
23.1199, Extinguishing Agent
Containers
23.1201, Fire Extinguishing System
Materials
rfrederick on PROD1PC67 with RULES
The following apply:
(a) No material in any fire
extinguishing system may react
chemically with any extinguishing agent
so as to create a hazard.
(b) Each system component in an
engine compartment must be fireproof.
Issued in Kansas City, Missouri on January
7, 2008.
John Colomy,
Acting Manager, Small Airplane Directorate,
Aircraft Certification Service.
[FR Doc. E8–849 Filed 1–17–08; 8:45 am]
VerDate Aug<31>2005
14:58 Jan 17, 2008
Food and Drug Administration
21 CFR Part 1271
The following applies:
(a) Each extinguishing agent container
must have a pressure relief to prevent
bursting of the container by excessive
internal pressures.
(b) The discharge end of each
discharge line from a pressure relief
connection must be located so that
discharge of the fire-extinguishing agent
would not damage the airplane. The line
must also be located or protected to
prevent clogging caused by ice or other
foreign matter.
(c) A means must be provided for
each fire extinguishing agent container
to indicate that the container has
discharged or that the charging pressure
is below the established minimum
necessary for proper functioning.
(d) The temperature of each container
must be maintained, under intended
operating conditions, to prevent the
pressure in the container from—
(1) Falling below that necessary to
provide an adequate rate of discharge; or
(2) Rising high enough to cause
premature discharge.
(e) If a pyrotechnic capsule is used to
discharge the fire extinguishing agent,
each container must be installed so that
temperature conditions will not cause
hazardous deterioration of the
pyrotechnic capsule.
4. SC 23.1201—Add the requirements
of § 23.1201 while deleting the phrase,
‘‘For commuter category airplanes.’’
BILLING CODE 4910–13–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Human Cells, Tissues, and Cellular and
Tissue-Based Products
CFR Correction
In Title 21 of the Code of Federal
Regulations, Parts 800 to 1299, revised
as of April 1, 2007, in part 1271, on page
718, § 1271.22 is reinstated to read as
follows:
§ 1271.22 How and where do I register and
submit an HCT/P list?
(a) You must use Form FDA 3356 for:
(1) Establishment registration,
(2) HCT/P listings, and
(3) Updates of registration and HCT/
P listing.
(b) You may obtain Form FDA 3356:
(1) By writing to the Center for
Biologics Evaluation and Research
(HFM–775), Food and Drug
Administration, 1401 Rockville Pike,
Rockville, MD 20852–1448, Attention:
Tissue Establishment Registration
Coordinator;
(2) By contacting any Food and Drug
Administration district office;
(3) By calling the CBER Voice
Information System at 1–800–835–4709
or 301–827–1800; or
(4) By connecting to https://
www.fda.gov/opacom/morechoices/
fdaforms/cber.html on the Internet.
(c)(1) You may submit Form FDA
3356 to the Center for Biologics
Evaluation and Research (HFM–775),
Food and Drug Administration, 1401
Rockville Pike, Rockville, MD 20852–
1448, Attention: Tissue Establishment
Registration Coordinator; or
(2) You may submit Form FDA 3356
electronically through a secure web
server at https://www.fda.gov/cber/
tissue/tisreg.htm.
[69 FR 68681, Nov. 24, 2004]
[FR Doc. 08–55500 Filed 1–17–08; 8:45 am]
BILLING CODE 1505–01–D
EQUAL EMPLOYMENT OPPORTUNITY
COMMISSION
29 CFR Part 1601
RIN 3046–AA83
Procedural Regulations Under Title VII
and ADA
Equal Employment
Opportunity Commission.
ACTION: Final rule.
AGENCY:
Jkt 214001
PO 00000
Frm 00011
Fmt 4700
Sfmt 4700
3387
SUMMARY: The Equal Employment
Opportunity Commission is eliminating
three bases for dismissal of charges in
its procedural regulations because they
are no longer needed to accomplish the
Commission’s case management goals.
DATES: Effective Date: February 19, 2008
FOR FURTHER INFORMATION CONTACT:
Thomas J. Schlageter, Assistant Legal
Counsel, or Mona Papillon, Senior
General Attorney, at (202) 663–4640
(voice) or (202) 663–7026 (TTY). Copies
of this final rule are also available in the
following alternate formats: Large print,
braille, audiotape and electronic file on
computer disk. Requests for this notice
in an alternative format should be made
to EEOC’s Publication Center at 1–800–
669–3362 (voice) or 1–800–800–3302
(TTY).
SUPPLEMENTARY INFORMATION: Prior to
1977, the Commission’s procedural
regulations only authorized dismissal
when the Commission issued a no cause
determination, a charge was untimely,
or a charge failed to state a claim. In
1977, the Commission adopted three
additional bases for dismissal in order
to resolve charges that were timely and
stated a claim, but where the
Commission was unable to issue a
determination on the merits for various
reasons. These three bases are currently
set out in § 1601.18(b) through (d).
Paragraph (b) permits dismissal when
the charging party fails to cooperate.
Paragraph (c) permits dismissal when
the charging party cannot be located.
Paragraph (d) permits dismissal when
the charging party refuses to accept an
offer of full relief for the harm alleged
in the charge.
In 1995, the Commission adopted
Priority Charge Handling Procedures
(PCHP) to facilitate flexibility and
permit more strategic use of resources.
Among other things, PCHP authorized
field offices to issue final
determinations when further
investigation was not likely to lead to
evidence establishing a violation of the
employment discrimination statutes.
Thus, § 1601.18(b) through (d) are no
longer needed to accomplish the
Commission’s case management goals.
Their elimination is also consistent with
EEOC’s procedural regulations
governing the Age Discrimination in
Employment Act and the Equal Pay Act
which do not contain the dismissal
bases of failure to cooperate, to locate,
and to accept full relief.
In addition, the continued inclusion
of these dismissal bases in the
regulations is causing unnecessary
confusion. There is a split in the courts
regarding the proper interpretation of
paragraphs (b) through (d). Compare
E:\FR\FM\18JAR1.SGM
18JAR1
]]>Agencies
[Federal Register Volume 73, Number 13 (Friday, January 18, 2008)]
[Rules and Regulations]
[Page 3387]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-55500]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1271
Human Cells, Tissues, and Cellular and Tissue-Based Products
CFR Correction
In Title 21 of the Code of Federal Regulations, Parts 800 to 1299,
revised as of April 1, 2007, in part 1271, on page 718, Sec. 1271.22
is reinstated to read as follows:
Sec. 1271.22 How and where do I register and submit an HCT/P list?
(a) You must use Form FDA 3356 for:
(1) Establishment registration,
(2) HCT/P listings, and
(3) Updates of registration and HCT/P listing.
(b) You may obtain Form FDA 3356:
(1) By writing to the Center for Biologics Evaluation and Research
(HFM-775), Food and Drug Administration, 1401 Rockville Pike,
Rockville, MD 20852-1448, Attention: Tissue Establishment Registration
Coordinator;
(2) By contacting any Food and Drug Administration district office;
(3) By calling the CBER Voice Information System at 1-800-835-4709
or 301-827-1800; or
(4) By connecting to https://www.fda.gov/opacom/morechoices/
fdaforms/cber.html on the Internet.
(c)(1) You may submit Form FDA 3356 to the Center for Biologics
Evaluation and Research (HFM-775), Food and Drug Administration, 1401
Rockville Pike, Rockville, MD 20852-1448, Attention: Tissue
Establishment Registration Coordinator; or
(2) You may submit Form FDA 3356 electronically through a secure
web server at https://www.fda.gov/cber/tissue/tisreg.htm.
[69 FR 68681, Nov. 24, 2004]
[FR Doc. 08-55500 Filed 1-17-08; 8:45 am]
BILLING CODE 1505-01-D
